Skip to main content

Revcovi Disease Interactions

There is 1 disease interaction with Revcovi (elapegademase).

Moderate

Elapegademase (applies to Revcovi) severe thrombocytopenia

Moderate Potential Hazard, Moderate plausibility.

Elapegademase is administered by IM injection, and it should be used with caution in patients with thrombocytopenia as there is a risk of bleeding on the injection site. Elapegademase should not be used if thrombocytopenia is severe.

References

  1. (2018) "Product Information. Revcovi (elapegademase)." Leadiant Biosciences, Inc.

Revcovi drug interactions

There are 2 drug interactions with Revcovi (elapegademase).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer